TP53 and cancer: In summary, while current paradigms primarily focus on how mutations in key genes controlling cell proliferation and survival contribute to the evolution of cancer, the data presented here, together with previous studies, indicate that greater focus on how carcinogenic contexts impact on selection of cells with oncogenic events such as p53 disruption may be critical for understanding, preventing, and perhaps even treating cancers.